Supervised drug consumption in Vancouver: History, evolving practices and next steps

Dr. Thomas Kerr
Co-Director, Urban Health Research Initiative, BC Centre for Excellence in HIV/AIDS


This talk is open to the public
A light lunch will be served

The Forefront Lectures are accredited for 1.0 Mainpro-M1 credit (College of Family Physicians of Canada)

Eventbrite - Forefront Lectures

For more information, please contact education@cfenet.ubc.ca / local 66255


Dr. Thomas Kerr, is Co-Director of the Urban Health Research Initiative at the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and a Professor of Medicine at the University of British Columbia. Dr. Kerr is a principal-/co-investigator of studies involving people who use drugs and individuals living with HIV/AIDS in Vancouver and elsewhere internationally, including in Thailand, the U.S., Russia and Australia. Dr. Kerr was a principal investigator of the scientific evaluation of Insite, North America’s first safer injecting facility.



Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025